title: Boehringer Ingelheim and Eli Lilly and Company announce strategic alliance to bring new diabetes treatments to patients worldwide.
mesh_terms: D003299:Cooperative Behavior; D055808:Drug Discovery; D004345:Drug Industry; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007373:Interinstitutional Relations
chemical_list: D015507:Drugs, Investigational; D007004:Hypoglycemic Agents